bal, Top VC Backed Companies, Q4 2011 – Q4 2012 27
Table 19: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 – Q4 2012 28
Table 20: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q4 2012 29
Table 21: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q4 2011 - Q4 2012 30
Table 22: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 32
Table 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 33
Table 24: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2011 - Q4 2012 34
Table 25: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2012 35
Table 26: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2012 35
Table 27: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q4 2012 36
Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q4 2011 - Q4 2012 37
Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q4 2011 - Q4 2012 39
Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q4 2011 - Q4 2012 40
Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 41
Table 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Value
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends2.
Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project3.
Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan4.
Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board5.
Frost & Sullivan: Investments in Healthcare Improvements to Bolster the Integration of Picture Archiving and Communications Systems in Latin America6.
Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan7.
Beyond Lucid Technologies Receives Funding From Dalmore Investments8.
Silicon Photonics: Big Investments, Small Business9.
Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative10.
Berkery Noyes Releases First Half 2012 M&A Report For the Healthcare/Pharma Information and Technology Industry11.
Biopharma M&A Trends Hold Steady, But Deals Declined in 2011